MENU
ALEC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Alector (ALEC) Earnings Date & Reports
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
ALEC is expected to report earnings to rise 10.71% to -23 cents per share on July 30
Q2'26
Est.
$-0.23
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.05
Q3'25
Beat
by $0.06
Q2'25
Beat
by $0.17
The last earnings report on May 07 showed earnings per share of -20 cents, beating the estimate of -28 cents. With 73.96K shares outstanding, the current market capitalization sits at 197.62M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of therapeutics for Alzheimer's disease and other neurodegenerative disorders
Industry Biotechnology
Profile
Details
Industry
Biotechnology
Address
131 Oyster Point Boulevard
Phone
+1 415 231-5660
Employees
103
Web
https://www.alector.com